Evidence map›Paper›PMID 34128151›Full record

ArticleAAPS PharmSciTech2021

Correction to: Development of Apremilast Solid Dispersion Using TPGS and PVPVA with Enhanced Solubility and Bioavailability.

Liuhong Yang, Penghui Wu, Jinchao Xu, Dihuan Xie, Zhongqing Wang, Qian Wang, Yong Chen, Chuan Hua Li, Jiaxin Zhang, Hangping Chen and 1 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Liuhong YangHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China.
Penghui WuHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China.
Jinchao XuHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China.
Dihuan XieHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China.
Zhongqing WangHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China.
Qian WangHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China.
Yong ChenHEC Research and Development Center, HEC Pharm Group, Dongguan, 523871, China. ChenYong@hec.cn.
Chuan Hua LiHunan Provincial Key Laboratory of Xiangnan Rare-Precious Metals Compounds and Applications, College of Chemical Biology and Environmental Engineering, Xiangnan University, Chenzhou, 423043, China.
Jiaxin ZhangCollege of Pharmacy, Yanbian University, Yanji, 133002, China.
Hangping ChenCollege of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, 510632, China.
Guilan QuanCollege of Pharmacy, Jinan University, 601 Huangpu Avenue West, Guangzhou, 510632, China. quanguilan@jnu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34128151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.